☰

Suzanne Petri, MD - Publications

Affiliations: 
Hanover University, Germany, Hannover, Niedersachsen, Germany 
Tree Info Grants Similar researchers PubMed Report error

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Pinto S, Petri S, Madeira S, Swash M, de Carvalho M. Spreading in ALS: The relative impact of upper and lower motor neuron involvement. Annals of Clinical and Translational Neurology. 7: 1181-1192. PMID 32558369 DOI: 10.1002/acn3.51098  0.364
2020 Wimmer T, Schreiber F, Hensiek N, Garz C, Kaufmann J, Machts J, Vogt S, Prudlo J, Dengler R, Petri S, Heinze HJ, Nestor PJ, Vielhaber S, Schreiber S. The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI. Scientific Reports. 10: 1783. PMID 32020025 DOI: 10.1038/S41598-020-58687-Z  0.37
2019 Korner S, Kammeyer J, Zapf A, Kuzma-Kozakiewicz M, Piotrkiewicz M, Kuraszkiewicz B, Goszczynska H, Gromicho M, Grosskreutz J, Andersen PM, de Carvalho M, Petri S. Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population. Aging and Disease. 10: 205-216. PMID 31011473 DOI: 10.14336/AD.2018.0327  0.309
2019 Kefalakes E, Sarikidi A, Bursch F, Ettcheto M, Schmuck M, Rumpel R, Grothe C, Petri S. Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1 amyotrophic lateral sclerosis mice. The European Journal of Neuroscience. 50: 3028-3045. PMID 30883949 DOI: 10.1111/ejn.14405  0.345
2019 Bursch F, Rath KJ, Sarikidi A, Böselt S, Kefalakes E, Osmanovic A, Thau-Habermann N, Klöß S, Köhl U, Petri S. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1 mouse model of amyotrophic lateral sclerosis. Journal of Tissue Engineering and Regenerative Medicine. 13: 649-663. PMID 30811816 DOI: 10.1002/term.2846  0.398
2019 Körner S, Thau-Habermann N, Kefalakes E, Bursch F, Petri S. Expression of the axon-guidance protein receptor Neuropilin 1 is increased in the spinal cord and decreased in muscle of a mouse model of amyotrophic lateral sclerosis. The European Journal of Neuroscience. 49: 1529-1543. PMID 30589468 DOI: 10.1111/ejn.14326  0.425
2019 Kefalakes E, Böselt S, Sarikidi A, Ettcheto M, Bursch F, Naujock M, Stanslowsky N, Schmuck M, Barenys M, Wegner F, Grothe C, Petri S. Characterizing the multiple roles of FGF-2 in SOD1 ALS mice in vivo and in vitro. Journal of Cellular Physiology. 234: 7395-7410. PMID 30370540 DOI: 10.1002/jcp.27498  0.405
2018 Schreiber S, Spotorno N, Schreiber F, Acosta-Cabronero J, Kaufmann J, Machts J, Debska-Vielhaber G, Garz C, Bittner D, Hensiek N, Dengler R, Petri S, Nestor PJ, Vielhaber S. Significance of CSF NfL and tau in ALS. Journal of Neurology. 265: 2633-2645. PMID 30187162 DOI: 10.1007/s00415-018-9043-0  0.318
2018 Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, Andersen PM, Petri S, Thal DR, Michaelis J, Otto M, Just S, Ludolph AC, Danzer KM, Freischmidt A, et al. Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cellular and Molecular Life Sciences : Cmls. PMID 30030593 DOI: 10.1007/s00018-018-2873-1  0.304
2018 Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, Naujock M, Günther R, Jin M, Stanslowsky N, Reinhardt P, Sterneckert J, Frickenhaus M, Pan-Montojo F, Storkebaum E, ... ... Petri S, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nature Communications. 9: 335. PMID 29362359 DOI: 10.1038/S41467-017-02299-1  0.323
2017 Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R, Ordovás L, Patel A, Welters M, Vanwelden T, Geens N, Tricot T, Benoy V, Steyaert J, Lefebvre-Omar C, ... ... Petri S, et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nature Communications. 8: 861. PMID 29021520 DOI: 10.1038/S41467-017-00911-Y  0.302
2016 Wais V, Rosenbohm A, Petri S, Kollewe K, Hermann A, Storch A, Hanisch F, Zierz S, Nagel G, Kassubek J, Weydt P, Brettschneider J, Weishaupt JH, Ludolph AC, Dorst J. The concept and diagnostic criteria of primary lateral sclerosis. Acta Neurologica Scandinavica. 136: 204-211. PMID 27858953 DOI: 10.1111/ane.12713  0.325
2016 Naujock M, Stanslowsky N, Bufler S, Naumann M, Reinhardt P, Sterneckert J, Kefalakes E, Kassebaum C, Bursch F, Lojewski X, Storch A, Frickenhaus M, Boeckers TM, Putz S, Demstre M, ... ... Petri S, et al. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from ALS Patient-Derived Induced Pluripotent Stem Cells. Stem Cells (Dayton, Ohio). PMID 26946488 DOI: 10.1002/Stem.2354  0.332
2016 Körner S, Böselt S, Wichmann K, Thau-Habermann N, Zapf A, Knippenberg S, Dengler R, Petri S. The Axon Guidance Protein Semaphorin 3A Is Increased in the Motor Cortex of Patients With Amyotrophic Lateral Sclerosis. Journal of Neuropathology and Experimental Neurology. 75: 326-333. PMID 26921371 DOI: 10.1093/jnen/nlw003  0.339
2015 Getter T, Zaks I, Barhum Y, Ben-Zur T, Böselt S, Gregoire S, Viskind O, Shani T, Gottlieb H, Green O, Shubely M, Senderowitz H, Israelson A, Kwon I, Petri S, et al. A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). Chemmedchem. 10: 850-61. PMID 25772747 DOI: 10.1002/cmdc.201500045  0.352
2015 Knippenberg S, Rath KJ, Böselt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. Journal of Tissue Engineering and Regenerative Medicine. PMID 25641599 DOI: 10.1002/term.1972  0.516
2015 Naujock M, Wegner F, Petri S. Electrophysiological Characterization of Induced Pluripotent Stem Cells (iPSC) as in Vitro Models for Motor Neuron Diseases | Elektrophysiologische Charakterisierung induzierbarer pluripotenter Stammzellen (iPSC) als in vitro-Modelle von Motoneuronerkrankungen Klinische Neurophysiologie. 46: 197-202. DOI: 10.1055/s-0041-106972  0.301
2013 Knippenberg S, Sipos J, Thau-Habermann N, Körner S, Rath KJ, Dengler R, Petri S. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model. Journal of Neuropathology and Experimental Neurology. 72: 1052-61. PMID 24128678 DOI: 10.1097/NEN.0000000000000004  0.44
2013 Sun H, Bénardais K, Stanslowsky N, Thau-Habermann N, Hensel N, Huang D, Claus P, Dengler R, Stangel M, Petri S. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. Plos One. 8: e72926. PMID 24069165 DOI: 10.1371/journal.pone.0072926  0.374
2013 Knippenberg S, Skripuletz T, Rath KJ, Thau N, Gudi V, Pul R, Körner S, Dengler R, Stangel M, Petri S. CDP-choline is not protective in the SOD1-G93A mouse model of ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 284-90. PMID 23286744 DOI: 10.3109/21678421.2012.745569  0.496
2013 Sun H, Knippenberg S, Thau N, Ragancokova D, Körner S, Huang D, Dengler R, Döhler K, Petri S. Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice. Cellular and Molecular Neurobiology. 33: 347-57. PMID 23271639 DOI: 10.1007/s10571-012-9900-9  0.439
2013 Körner S, Böselt S, Thau N, Rath KJ, Dengler R, Petri S. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neuro-Degenerative Diseases. 11: 141-52. PMID 22796962 DOI: 10.1159/000338048  0.467
2012 Thau N, Knippenberg S, Körner S, Rath KJ, Dengler R, Petri S. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. Journal of Neuropathology and Experimental Neurology. 71: 1064-74. PMID 23147503 DOI: 10.1097/NEN.0b013e318275df4b  0.36
2012 Petri S, Körner S, Kiaei M. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurology Research International. 2012: 878030. PMID 23050144 DOI: 10.1155/2012/878030  0.366
2012 Knippenberg S, Thau N, Dengler R, Brinker T, Petri S. Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. Plos One. 7: e36857. PMID 22745655 DOI: 10.1371/journal.pone.0036857  0.436
2012 Thau N, Jungnickel J, Knippenberg S, Ratzka A, Dengler R, Petri S, Grothe C. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2. Neurobiology of Disease. 47: 248-57. PMID 22542539 DOI: 10.1016/j.nbd.2012.04.008  0.451
2012 Knippenberg S, Thau N, Schwabe K, Dengler R, Schambach A, Hass R, Petri S. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neuro-Degenerative Diseases. 9: 107-20. PMID 22122965 DOI: 10.1159/000331327  0.467
2011 Swarup V, Phaneuf D, Dupré N, Petri S, Strong M, Kriz J, Julien JP. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways. The Journal of Experimental Medicine. 208: 2429-47. PMID 22084410 DOI: 10.1084/Jem.20111313  0.411
2011 Cordes AL, Jahn K, Hass R, Schwabe K, Weissinger EM, Ganser A, Götz F, Dengler R, Krauss JK, Petri S. Intramedullary spinal cord implantation of human CD34+ umbilical cord-derived cells in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 325-30. PMID 21812628 DOI: 10.3109/17482968.2011.580850  0.422
2011 Petri S, Meyer T. [Motor neuron diseases]. Der Nervenarzt. 82: 697-706. PMID 21626001 DOI: 10.1007/s00115-010-2967-y  0.352
2011 Heurich B, El Idrissi NB, Donev RM, Petri S, Claus P, Neal J, Morgan BP, Ramaglia V. Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis. Journal of Neuroimmunology. 235: 104-9. PMID 21501881 DOI: 10.1016/j.jneuroim.2011.03.011  0.47
2011 Körner S, Kollewe K, Fahlbusch M, Zapf A, Dengler R, Krampfl K, Petri S. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle & Nerve. 43: 636-42. PMID 21484822 DOI: 10.1002/mus.21936  0.366
2011 Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF, Kiaei M. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology & Medicine. 51: 88-96. PMID 21457778 DOI: 10.1016/J.Freeradbiomed.2011.03.027  0.711
2010 Janssen C, Schmalbach S, Boeselt S, Sarlette A, Dengler R, Petri S. Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology. 69: 573-81. PMID 20467334 DOI: 10.1097/NEN.0b013e3181ddd404  0.328
2010 Knippenberg S, Thau N, Dengler R, Petri S. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behavioural Brain Research. 213: 82-7. PMID 20450936 DOI: 10.1016/j.bbr.2010.04.042  0.477
2010 Schmalbach S, Petri S. Histone deacetylation and motor neuron degeneration. Cns & Neurological Disorders Drug Targets. 9: 279-84. PMID 20406183  0.399
2010 Halter B, Gonzalez de Aguilar JL, Rene F, Petri S, Fricker B, Echaniz-Laguna A, Dupuis L, Larmet Y, Loeffler JP. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology & Medicine. 48: 915-23. PMID 20079427 DOI: 10.1016/J.Freeradbiomed.2010.01.014  0.33
2010 Dengler R, Petri S, Mohammadi B, Kollewe K. S35-3 Detection of upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) Clinical Neurophysiology. 121: S52. DOI: 10.1016/S1388-2457(10)60217-9  0.346
2009 Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M. Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 220: 191-7. PMID 19733563 DOI: 10.1016/J.Expneurol.2009.08.028  0.635
2009 Petri S, Krampfl K, Kuhlemann K, Dengler R, Grothe C. Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients. Histochemistry and Cell Biology. 131: 509-19. PMID 19096867 DOI: 10.1007/s00418-008-0549-x  0.394
2008 Sarlette A, Krampfl K, Grothe C, Neuhoff Nv, Dengler R, Petri S. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology. 67: 1055-62. PMID 18957896 DOI: 10.1097/NEN.0b013e31818b4906  0.428
2008 Janssen C, Sarlette A, Dengler R, Krampfl K, Petri S. Distribution of histone deacetylases in post-mortem brain and spinal cord of ALS patients and controls Aktuelle Neurologie. 35. DOI: 10.1055/S-0028-1086667  0.317
2008 Fahlbusch M, Kollewe K, Dengler R, Petri S, Krampfl K. Onset and spreading patterns of upper and lower motor neuron symptoms in ALS Aktuelle Neurologie. 35. DOI: 10.1055/s-0028-1086661  0.302
2008 Sarlette A, Krampfl K, von Neuhoff N, Dengler R, Petri S. Reduced mRNA and protein expression of the transcriptional co-activator PGC-1alpha in post-mortem tissue of ALS patients and in the G93A transgenic ALS mouse model Aktuelle Neurologie. 35. DOI: 10.1055/S-0028-1086658  0.349
2007 Petri S, Calingasan NY, Alsaied OA, Wille E, Kiaei M, Friedman JE, Baranova O, Chavez JC, Beal MF. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 102: 991-1000. PMID 17630988 DOI: 10.1111/J.1471-4159.2007.04604.X  0.632
2006 Petri S, Kiaei M, Wille E, Calingasan NY, Flint Beal M. Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice. Journal of the Neurological Sciences. 251: 44-9. PMID 17049562 DOI: 10.1016/J.Jns.2006.08.013  0.472
2006 Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 98: 1141-8. PMID 16895581 DOI: 10.1111/J.1471-4159.2006.04018.X  0.722
2006 Kiaei M, Petri S, Kipiani K, Gardian G, Choi DK, Chen J, Calingasan NY, Schafer P, Muller GW, Stewart C, Hensley K, Beal MF. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2467-73. PMID 16510725 DOI: 10.1523/Jneurosci.5253-05.2006  0.667
2006 Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. Journal of Neurochemistry. 96: 1349-61. PMID 16478527 DOI: 10.1111/J.1471-4159.2006.03619.X  0.719
2006 Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, Beal MF. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease. 22: 40-9. PMID 16289867 DOI: 10.1016/J.Nbd.2005.09.013  0.734
2005 Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neuro-Degenerative Diseases. 2: 246-54. PMID 16909005 DOI: 10.1159/000090364  0.769
2005 Petri S, Schmalbach S, Grosskreutz J, Krampfl K, Grothe C, Dengler R, Van Den Bosch L, Robberecht W, Bufler J. The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice. Journal of the Neurological Sciences. 238: 25-30. PMID 16087196 DOI: 10.1016/j.jns.2005.06.005  0.368
2005 Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 93: 403-11. PMID 15816863 DOI: 10.1111/J.1471-4159.2005.03024.X  0.761
Show low-probability matches.